statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

How Is The Market Feeling About Krystal Biotech?

KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600 KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400...

Krystal Biotech is on the Move, Here's Why the Trend Could be Sustainable

While 'the trend is your friend' when it comes to short-term investing or trading, timing entries into the trend is a key determinant of success. And increasing the odds of success by making sure the...

Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting

Intratumoral delivery of HSV-1 encoded IL-12 and IL-2 enhanced local and systemic effector T-cell responses in cold tumor preclinical modelPITTSBURGH, April 04, 2024 (GLOBE NEWSWIRE) -- Krystal...

Brokerages Set Krystal Biotech, Inc. (NASDAQ:KRYS) Price Target at $157.67

Shares of Krystal Biotech, Inc. (NASDAQ:KRYS - Get Free Report) have earned a consensus rating of "Buy" from the nine analysts that are covering the firm, MarketBeat.com reports. Nine analysts have...

Krystal Biotech (KRYS, $177.93) Stochastic Oscillator left the overbought zone on March 28, 2024

This is a signal that KRYS's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Attovia Enhances Clinical and Development Expertise with Appointment of Chief Medical Officer and Clinical and Scientific Advisory Boards

-- Hubert Chen, accomplished drug developer and pharma executive, joins as Chief Medical Officer -- Industry veterans and leading academic experts joined Attovia's Clinical and Scientific...

Krystal Biotech (KRYS, $169.46) Stochastic Oscillator left the oversold zone on March 25, 2024

This is a signal that KRYS's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

Krystal Biotech (KRYS, $167.24) entered Downtrend as Momentum indicator drops below 0 level on Mar 22, 2024

This indicator may be signaling that KRYS's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Krystal Biotech, Inc. engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.

Volume	234,535.00
52-Wk High	$219.34
52-Wk Low	$93.95

KRYS Krystal Biotech Inc

About

Feed

News

Sentiment

Earnings

Fundamentals